Analytical method development for the simultaneous quantitation of dexmedetomidine and three potential metabolites in plasma

Journal of Chromatography A

Volumn 762, Issue 1-2, 1997, Pages 281-291

  Hui, Y H ^a   Marsh, K C ^a   Menacherry, S ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Derivatization; Dexmedetomidine; GC; Medetomidine; Sample preparation

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; DEXMEDETOMIDINE; DRUG METABOLITE;

ACCURACY; CONFERENCE PAPER; CONTROLLED STUDY; DERIVATIZATION; DRUG BLOOD LEVEL; DRUG DETERMINATION; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MASS SPECTROMETRY; NORMAL HUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SOLID PHASE EXTRACTION; TECHNIQUE;

EID: 0031581875     PISSN: 00219673     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9673(96)00965-X     Document Type: Conference Paper

References (7)

1. [1] R. Aantaa, A. Kallio and R. Virtanen, Drugs Future, 18 (1993) 49-56.
2. [2] J.B. Dyck and S.L. Shafer, Anaesthetic Pharmacol. Rev., 1 (1993) 238-245.
3. [3] L. Veorilehto, J.S. Salonen and M. Anttila, J. Chromatogr., 497 (1989) 282-287.
4. [4] M. Salonen and M. Maze, Pharmacol. Toxicol., 73 (1993) 254-256.
5. [5] J.S. Salonen, Acta Vet. Scand., 85 (1989) 49-54.
6. [6] J.S. Salonen and M. Eloranta, Xenobiotica, 20 (1990) 471-480.
7. [7] J.S. Salonen, Pharmacol. Toxicol., 69 (1991) 1-4.